The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue

Journal of Controlled Release

Volumn 154, Issue 3, 2011, Pages 249-257

  Ali, Omar A ^b,c   Doherty, Edward ^b   Bell, William J ^a   Fradet, Tracie ^a   Hudak, Jebecka ^a   Laliberte, Marie Therese ^a   Mooney, David J ^b,c   Emerich, Dwaine F ^a  

^a InCytu Inc   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Brain tumor; Cancer vaccine; Glioma; Immunotherapy; PLG

Indexed keywords

BRAIN TUMORS; CANCER VACCINE; GLIOMA; IMMUNOTHERAPY; PLG;

ANIMALS; BRAIN; BRAIN MODELS; DENDRIMERS; OLIGONUCLEOTIDES; TUMORS;

VACCINES;

CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MICROSPHERE; POLYGLACTIN; POLYMER; TUMOR EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG IMPLANTATION; GLIOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRAIN; BRAIN NEOPLASMS; CANCER VACCINES; GLIOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY; MALE; OLIGODEOXYRIBONUCLEOTIDES; POLYGLACTIN 910; POROSITY; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80052520489     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.06.021     Document Type: Article

References (29)

1. J.M. Legler, L.A. Gloeckler Ries, M.A. Smith, J.L. Warren, E.F. Heineman, R.S. Kaplan, and M.S. Linet Brain and other central nervous system cancers: recent trends in incidence and mortality J. Nat. Cancer Inst. 91 1999 1382 1390 (Pubitemid 29399996)
2. H. Okada Brain tumor immunotherapy with type-1 polarizing strategies Ann. N. Y. Acad. Sci. 1174 2009 18 23
3. O.M. Grauer, J.W. Molling, E. Benniink, L.W. Toonen, R.P. Sutmuller, S. Nierkens, and G.J. Adema TLR ligands in the local treatment of established intracerebral murine gliomas J. Immunol. 181 2008 6720 6729
4. O.M. Grauer, P. Wesseling, and G.J. Adema Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol. 19 2009 674 693
5. O.A. Ali, N. Huebsch, L. Cao, G. Dranoff, and D.J. Mooney Infection-mimicking materials to program dendritic cells in situ Nat. Mater. 2 2009 151 158
6. O.A. Ali, D. Emerich, G. Dranoff, and D.J. Mooney In situ regulation of DC subsets and T cells mediates tumor regression in mice Sci. Transl. Med. 1 2009 8 19
7. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat. Biotechnol. 19 2001 1029 1034 (Pubitemid 33041886)
8. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, and R. Langer Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres Pharm. Res. 8 1991 713 720
9. D.F. Emerich, D.J. Mooney, H. Storrie, R.S. Babu, and J.H. Kordower Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease Neurotox. Res. 1 2010 66 74
10. D.F. Emerich, S.R. Winn, Y. Hu, J. Marsh, P. Snodgrass, D. LaFreniere, T. Wiens, B.P. Hasler, and R.T. Bartus Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors Pharm. Res. 17 2000 767 775 (Pubitemid 30666955)
11. J.S. Yu, G. Liu, H. Ying, W.H. Yong, K.L. Black, and C.J. Wheeler Vaccination with tumor lysate-pulsed dendritic cells elicits antigen specific cytotoxic T cells in patients with malignant glioma Cancer Res. 64 2004 4973 4979 (Pubitemid 38924545)
12. E. Gilboa Dendritic cell based vaccines J. Clin. Invest. 117 2007 1195 1203
13. R. Yamanaka, T. Abe, N. Yajima, N. Tsuchiya, J. Homma, T. Kobayashi, M. Narita, M. Takahashi, and R. Tanaka Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial Br. J. Cancer 89 2003 1172 1179 (Pubitemid 37363398)
14. M. Ingram, J.G. Buckwalter, D.B. Jacques, R.M. Freshwater, G.B. Abts, K. Techy, C.H. Miyagi, R.W. Shelden, and L.W. English Immunotherapy for recurrent malignant glioma: an interim report on survival Neurol. Res. 12 1990 265 273
15. R.E. Nair, Y.S. Jong, S.A. Jones, A. Sharma, E. Mathiowitz, and N.K. Egilmez IL-12 + GM-CSF microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve long-term cure due to the inability to maintain effector T-cell activity J. Immunother. 29 2006 2006 10 20
16. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
17. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, N.A. Vick, K. Black, M. Sisti, S. Brem, and G. Mohr Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas Lancet 345 1995 1008 1012
18. F. Gu, H.M. Younes, A.O. El-Kadi, R.J. Neufeld, and B.G. Amsden Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer J. Control. Release 102 2005 607 617 (Pubitemid 40170204)
19. D.A. Zaharoff, B.S. Hoffman, H.B. Hooper, C.J. Benjamin, K.K. Khurana, K.W. Hance, C.J. Rogers, P.A. Pinto, J. Schlom, and J.W. Greiner Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12 Cancer Res. 69 2009 6192 6199
20. J. Banchereau, and R.M. Steinman Taking dendritic cells into medicine Nature 49 2007 419 426 (Pubitemid 47509552)
21. K. Holger, B. Frank, E. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat. Med. 13 2007 552 559 (Pubitemid 46830615)
22. S.S. Neelapu, S. Baskar, B.L. Gause, C.B. Kobrin, T.M. Watson, A.R. Frye, R. Pennington, L. Harvey, E.S. Jaffe, R.J. Robb, M.C. Popescu, and L.W. Kwak Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen Clin. Cancer Res. 24 2004 8309 8317 (Pubitemid 40053391)
23. J.A. Hubbell, S.N. Thomas, and M.A. Swartz Materials engineering for immunomodulation Nature 462 2009 449 460
24. O.A. Ali, and D.J. Mooney Immunologically active biomaterials for cancer immunotherapy Curr. Top. Microbiol. Immunol. 344 2011 279 297
25. D.F. Emerich, S.R. Winn, P. Snodgrass, D. LaFreniere, M. Agostino, T. Wiens, H. Xiong, and R.T. Bartus Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors Pharm. Res. 17 2000 776 781 (Pubitemid 30666956)
26. P. Menei, M.C. Venier, E. Gamelin, J.P. Saint-André, G. Hayek, E. Jadaud, D. Fournier, P. Mercier, G. Guy, and J.P. Benoit Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study Cancer 1999 325 330 (Pubitemid 29327590)
27. P. Menei, L. Capelle, J.S. Guyotat, Fuentes, R. Assaker, B. Bataille, P. François, D. Dorwling-Carter, P. Paquis, L. Bauchet, F. Parker, J. Sabatier, N. Faisant, and J.P. Benoit Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial Neurosurgery 2005 242 248
28. L.R. Hochberg, M.D. Serruya, G.M. Friehs, J.A. Mukand, M. Saleh, A.H. Caplan, A. Branner, D. Chen, R.D. Penn, and J.P. Donoghue Neuronal ensemble control of prosthetic devices by a human with tetraplegia Nature 2006 164 171 (Pubitemid 44086558)
29. R. Bhandari, S. Negi, and F. Solzbacher Wafer scale fabrication of penetrating neural electrode arrays Biomed. Microdevices 2010 797 807